Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
O
036220
vs
K
KOSPI 200
Over the past 12 months, Osang HealthCare Co Ltd has underperformed KOSPI 200, delivering a return of -60% compared to KOSPI 200's +57% growth.
Stocks Performance
036220 vs KOSPI 200
Performance Gap
036220 vs KOSPI 200
Performance By Year
036220 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Osang HealthCare Co Ltd
Glance View
Osang HealthCare makes in vitro diagnostic products, which are tests and instruments used to find disease from blood, urine, and other samples. Its core business is selling test kits, reagents, and analysis equipment that hospitals, clinics, laboratories, and distributors use for routine screening and diagnosis. The company also supplies some rapid tests that can be used outside large laboratory settings, which gives it a role in both professional medical testing and point-of-care testing. The company earns money mainly by selling disposable test kits and reagents, along with the instruments needed to run those tests. In this business, the recurring revenue comes from repeat purchases of test materials, while the instruments help lock in demand for the company’s own consumables. That makes Osang HealthCare more than a one-time equipment seller; it is part of the medical testing supply chain that supports ongoing diagnostics. What makes the business model different is that it sits close to the actual diagnosis step, rather than treating patients directly. It competes on test accuracy, speed, ease of use, and the ability to manufacture products that meet medical standards. That puts the company in a niche where regulatory approval, product reliability, and relationships with healthcare buyers matter more than brand name alone.